Paroxysmal AV block epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}}{{Akash}}
{{CMG}}; {{AE}}{{Akash}}
==Overview==
==Overview==
Exact data reflecting the [[epidemiology]] of [[paroxysmal AV block]] is unavailable. However certain studies have shown an increased [[incidence]] in the elderly, no [[gender]] predisposition and an association with [[bundle branch blocks]].


==Epidemiology and Demographics==
==Epidemiology==
===Incidence===
*Given the difficulty in [[diagnosis]], [[sporadic]] presentation and sparse literature available, the exact [[incidence]] and [[prevalence]] of [[paroxysmal AV block]] is unknown.
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.


===Prevalence===
*'''An unpublished study done at Beth Israel Deaconess Medical Centre in collaboration with a [[cardiology]] department in the Netherlands''' found that [[paroxysmal AV bloc]]<nowiki/>k was most associated with '''[[RBBB]]<nowiki/>s followed by [[LBBB]]<nowiki/>s, [[intraventricular conduction delays]] and normal [[QRS complexes]]'''.  
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
**An age presentation of '''26-99 years of age, an equal [[incidence]] in both men and women and an increased [[prevalence]] in older individuals were also seen'''.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
**However, the association between [[paroxysmal AV block]] and [[RBBB]] is a matter of much debate, as it is not sure whether RBBB causes a direct effect or is a sign seen in an aging population.<ref name="pmid19632639">{{cite journal| author=Lee S, Wellens HJ, Josephson ME| title=Paroxysmal atrioventricular block. | journal=Heart Rhythm | year= 2009 | volume= 6 | issue= 8 | pages= 1229-34 | pmid=19632639 | doi=10.1016/j.hrthm.2009.04.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19632639  }} </ref>
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
*'''The ISSUE 2 study''' was characterised by a population of individuals with a '''high [[mean]] age, a history of recurrent [[syncope]] beginning in middle or older ages, and frequent injuries''' probably due to presentation without warning.<ref name="pmid16569653">{{cite journal| author=Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W | display-authors=etal| title=Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. | journal=Eur Heart J | year= 2006 | volume= 27 | issue= 9 | pages= 1085-92 | pmid=16569653 | doi=10.1093/eurheartj/ehi842 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16569653  }} </ref>
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
 
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==
{{Reflist|2}}
[[Category:Cardiology]]
[[Category:Cardiovascular diseases]]
[[Category:Arrythmia]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]
{{WH}}
{{WS}}

Revision as of 05:34, 11 July 2020

Paroxysmal AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paroxysmal AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paroxysmal AV block epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paroxysmal AV block epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paroxysmal AV block epidemiology and demographics

CDC on Paroxysmal AV block epidemiology and demographics

Paroxysmal AV block epidemiology and demographics in the news

Blogs on Paroxysmal AV block epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Paroxysmal AV block epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

Exact data reflecting the epidemiology of paroxysmal AV block is unavailable. However certain studies have shown an increased incidence in the elderly, no gender predisposition and an association with bundle branch blocks.

Epidemiology

  • The ISSUE 2 study was characterised by a population of individuals with a high mean age, a history of recurrent syncope beginning in middle or older ages, and frequent injuries probably due to presentation without warning.[2]

References

  1. Lee S, Wellens HJ, Josephson ME (2009). "Paroxysmal atrioventricular block". Heart Rhythm. 6 (8): 1229–34. doi:10.1016/j.hrthm.2009.04.001. PMID 19632639.
  2. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W; et al. (2006). "Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope". Eur Heart J. 27 (9): 1085–92. doi:10.1093/eurheartj/ehi842. PMID 16569653.